Literature DB >> 21400632

Influence of intensity-modulated radiation therapy technique on xerostomia and related quality of life in patients treated with intensity-modulated radiation therapy for nasopharyngeal cancer.

Laura Marucci1, Simona Marzi, Isabella Sperduti, Giuseppe Giovinazzo, Paola Pinnarò, Marcello Benassi, Lidia Strigari.   

Abstract

BACKGROUND: The purpose of this study was to compare 5-field and 7-field intensity-modulated radiation therapy (IMRT) techniques in terms of xerostomia and related quality of life in patients with nasopharyngeal cancer.
METHODS: Eight and 23 patients were treated with 5-field (group I) and 7-field (group II) techniques, respectively. The xerostomia was evaluated using the Radiation Therapy Oncology Group (RTOG) scale, stimulated and unstimulated salivary flow (SSF/USF), and xerostomia-related questionnaires (XQs). The assessments were done before and at 3, 6, 12, 18, and 24 months after radiotherapy.
RESULTS: The mean parotid dose was 45.7 Gy and 29.9 Gy and the ≥G3 toxicity at 24 months was 25% and 19% in group I and II, respectively. Sixty-three percent and 93% of patients recovered at least 25% of SSF pretherapy values. The XQ scores of both groups improved over time but more so in group II.
CONCLUSION: The 7-field technique decreases the mean parotid dose, reducing xerostomia assessed by the RTOG/XQ score.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21400632     DOI: 10.1002/hed.21736

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  7 in total

1.  A split-parotid delineation approach for dose optimization in volumetric modulated arc therapy for nasopharyngeal carcinoma patients with parapharyngeal space invasion and level IIa cervical lymph node involvements.

Authors:  Wei Xiao; Zhixiong Lin; Wuzhe Zhang; Mei Li; Vincent W C Wu
Journal:  Br J Radiol       Date:  2016-02-03       Impact factor: 3.039

2.  Functional swallowing outcomes in nasopharyngeal cancer treated with IMRT at 6 to 42 months post-radiotherapy.

Authors:  Margaret Patterson; Rowena Brain; Ronald Chin; David Veivers; Michael Back; Andrew Wignall; Thomas Eade
Journal:  Dysphagia       Date:  2014-08-13       Impact factor: 3.438

3.  Assessment of radiation-induced xerostomia: validation of the Italian version of the xerostomia questionnaire in head and neck cancer patients.

Authors:  Federica Pellegrino; Elena Groff; Luca Bastiani; Bruno Fattori; Guido Sotti
Journal:  Support Care Cancer       Date:  2014-09-19       Impact factor: 3.603

4.  Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy.

Authors:  Huixian Huang; Heming Lu; Guosheng Feng; Hailan Jiang; Jiaxin Chen; Jinjian Cheng; Qiang Pang; Zhiping Lu; Junzhao Gu; Luxing Peng; Shan Deng; Ying Mo; Danling Wu; Yinglin Wei
Journal:  Radiat Oncol       Date:  2015-09-17       Impact factor: 3.481

5.  The effect of parotid gland-sparing intensity-modulated radiotherapy on salivary composition, flow rate and xerostomia measures.

Authors:  T M Richards; T Hurley; L Grove; K J Harrington; G H Carpenter; G B Proctor; C M Nutting
Journal:  Oral Dis       Date:  2017-06-05       Impact factor: 3.511

6.  LASSO NTCP predictors for the incidence of xerostomia in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.

Authors:  Tsair-Fwu Lee; Ming-Hsiang Liou; Yu-Jie Huang; Pei-Ju Chao; Hui-Min Ting; Hsiao-Yi Lee; Fu-Min Fang
Journal:  Sci Rep       Date:  2014-08-28       Impact factor: 4.379

7.  Coconut Oil as a Novel Approach to Managing Radiation-Induced Xerostomia: A Primary Feasibility Study.

Authors:  Alexandra E Quimby; Debora Hogan; Diana Khalil; Matthew Hearn; Colette Nault; Stephanie Johnson-Obaseki
Journal:  Int J Otolaryngol       Date:  2020-08-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.